Exact Mass: 613.253636
Exact Mass Matches: 613.253636
Found 186 metabolites which its exact mass value is equals to given mass value 613.253636,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Ferrioxamine B
Ferrioxamine b belongs to the class of organic compounds known as n-acyl amines. N-acyl amines are compounds containing a fatty acid moiety linked to an amine group through an ester linkage. Ferrioxamine b is considered to be a practically insoluble (in water) and relatively neutral molecule. Ferrioxamine b exists in all living organisms, ranging from bacteria to humans.
Neoacrimarine E
Neoacrimarine E is found in citrus. Neoacrimarine E is an alkaloid from roots of Yalaha [several hybrid seedlings resulting from a cross of Duncan grapefruit (Citrus paradisi) and Dancy tangerine (Citrus tangerina)] (Rutaceae). Alkaloid from roots of Yalaha [several hybrid seedlings resulting from a cross of Duncan grapefruit (Citrus paradisi) and Dancy tangerine (Citrus tangerina)] (Rutaceae). Neoacrimarine E is found in citrus.
(1alpha,6alpha,14alpha)-8-acetoxy-13-hydroxy-1,6,16-trimethoxy-4-(methoxymethyl)aconitan-14-yl 4-methoxybenzoate|macrorhynine B
C33H43NO10 (613.2886818000001)
Asp Phe Phe Trp
Asp Phe Trp Phe
Asp Met Trp Tyr
Asp Met Tyr Trp
Asp Trp Phe Phe
Asp Trp Met Tyr
Asp Trp Tyr Met
Asp Tyr Met Trp
Asp Tyr Trp Met
Glu Phe Arg Tyr
Glu Phe Tyr Arg
Glu Arg Phe Tyr
Glu Arg Tyr Phe
Glu Tyr Phe Arg
Glu Tyr Arg Phe
Phe Asp Phe Trp
Phe Asp Trp Phe
Phe Glu Arg Tyr
Phe Glu Tyr Arg
Phe Phe Asp Trp
Phe Phe Trp Asp
Phe Met Met Trp
C30H39N5O5S2 (613.2392484000001)
Phe Met Trp Met
C30H39N5O5S2 (613.2392484000001)
Phe Arg Glu Tyr
Phe Arg Tyr Glu
Phe Val Trp Tyr
C34H39N5O6 (613.2900193999999)
Phe Val Tyr Trp
C34H39N5O6 (613.2900193999999)
Phe Trp Asp Phe
Phe Trp Phe Asp
Phe Trp Met Met
C30H39N5O5S2 (613.2392484000001)
Phe Trp Val Tyr
C34H39N5O6 (613.2900193999999)
Phe Trp Tyr Val
C34H39N5O6 (613.2900193999999)
Phe Tyr Glu Arg
Phe Tyr Arg Glu
Phe Tyr Val Trp
C34H39N5O6 (613.2900193999999)
Phe Tyr Trp Val
C34H39N5O6 (613.2900193999999)
Met Asp Trp Tyr
Met Asp Tyr Trp
Met Phe Met Trp
C30H39N5O5S2 (613.2392484000001)
Met Phe Trp Met
C30H39N5O5S2 (613.2392484000001)
Met Met Phe Trp
C30H39N5O5S2 (613.2392484000001)
Met Met Trp Phe
C30H39N5O5S2 (613.2392484000001)
Met Trp Asp Tyr
Met Trp Phe Met
C30H39N5O5S2 (613.2392484000001)
Met Trp Met Phe
C30H39N5O5S2 (613.2392484000001)
Met Trp Tyr Asp
Met Tyr Asp Trp
Met Tyr Trp Asp
Arg Glu Phe Tyr
Arg Glu Tyr Phe
Arg Phe Glu Tyr
Arg Phe Tyr Glu
Arg Tyr Glu Phe
Arg Tyr Phe Glu
Val Phe Trp Tyr
C34H39N5O6 (613.2900193999999)
Val Phe Tyr Trp
C34H39N5O6 (613.2900193999999)
Val Trp Phe Tyr
C34H39N5O6 (613.2900193999999)
Val Trp Tyr Phe
C34H39N5O6 (613.2900193999999)
Val Tyr Phe Trp
C34H39N5O6 (613.2900193999999)
Val Tyr Trp Phe
C34H39N5O6 (613.2900193999999)
Trp Asp Phe Phe
Trp Asp Met Tyr
Trp Asp Tyr Met
Trp Phe Asp Phe
Trp Phe Phe Asp
Trp Phe Met Met
C30H39N5O5S2 (613.2392484000001)
Trp Phe Val Tyr
C34H39N5O6 (613.2900193999999)
Trp Phe Tyr Val
C34H39N5O6 (613.2900193999999)
Trp Met Asp Tyr
Trp Met Phe Met
C30H39N5O5S2 (613.2392484000001)
Trp Met Met Phe
C30H39N5O5S2 (613.2392484000001)
Trp Met Tyr Asp
Trp Val Phe Tyr
C34H39N5O6 (613.2900193999999)
Trp Val Tyr Phe
C34H39N5O6 (613.2900193999999)
Trp Tyr Asp Met
Trp Tyr Phe Val
C34H39N5O6 (613.2900193999999)
Trp Tyr Met Asp
Trp Tyr Val Phe
C34H39N5O6 (613.2900193999999)
Tyr Asp Met Trp
Tyr Asp Trp Met
Tyr Glu Phe Arg
Tyr Glu Arg Phe
Tyr Phe Glu Arg
Tyr Phe Arg Glu
Tyr Phe Val Trp
C34H39N5O6 (613.2900193999999)
Tyr Phe Trp Val
C34H39N5O6 (613.2900193999999)
Tyr Met Asp Trp
Tyr Met Trp Asp
Tyr Arg Glu Phe
Tyr Arg Phe Glu
Tyr Val Phe Trp
C34H39N5O6 (613.2900193999999)
Tyr Val Trp Phe
C34H39N5O6 (613.2900193999999)
Tyr Trp Asp Met
Tyr Trp Phe Val
C34H39N5O6 (613.2900193999999)
Tyr Trp Met Asp
Tyr Trp Val Phe
C34H39N5O6 (613.2900193999999)
Neoacrimarine E
TAE684(NVP-TAE684)
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C141136 - ALK Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor
Skinasensyl
C34H39N5O6 (613.2900193999999)
Acetyl tetrapeptide-15 is a synthetic peptide used in the cosmetics for sensitive skin. Acetyl tetrapeptide-15 is derived from endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), a human μ-opioid agonist with selective anti-nociceptive effect. Acetyl tetrapeptide-15 reduces skin hyperreactivity producing inflammatory, chronic and neuropathic pain, by increasing the threshold of neuronal excitability in μ-opioid receptor via an endorphin-like pathway[1]. Acetyl tetrapeptide-15 is a synthetic peptide used in the cosmetics for sensitive skin. Acetyl tetrapeptide-15 is derived from endomorphin-2 (Tyr-Pro-Phe-Phe-NH2), a human μ-opioid agonist with selective anti-nociceptive effect. Acetyl tetrapeptide-15 reduces skin hyperreactivity producing inflammatory, chronic and neuropathic pain, by increasing the threshold of neuronal excitability in μ-opioid receptor via an endorphin-like pathway[1].
Aplaviroc hydrochloride
C254 - Anti-Infective Agent > C281 - Antiviral Agent > C1660 - Anti-HIV Agent C308 - Immunotherapeutic Agent > C63817 - Chemokine Receptor Antagonist
N-(Ethylsulfonyl)-5-propoxy-L-tryptophyl-N~1~-{4-[amino(imino)methyl]benzyl}-L-glutamamide
C29H39N7O6S (613.2682394000001)
N-Acetyl-N-[1-(1,1-biphenyl-4-ylmethyl)-2-oxoazepan-3-YL]-4-[difluoro(phosphono)methyl]phenylalaninamide
C31H34F2N3O6P (613.2153178000001)
131-hydroxy-magnesium-protoporphyrin IX 13-monomethyl ester
Euphorbia diterpenoid 2
A tetracyclic diterpenoid isolated from the whole plant of Euphorbia decipiens and exhibits inhibitory activity against urease.
1-[[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-10-[[oxo-[4-(trifluoromethyl)anilino]methyl]amino]-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methyl-3-phenylurea
3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
3-(4-fluorophenyl)-1-[[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
N-[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2R,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide
N-[(2S,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2S,3R)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[oxo-[4-(trifluoromethyl)anilino]methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-pyridinecarboxamide
N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide
N-[(2R,3R)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
3-(4-fluorophenyl)-1-[[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
3-(4-fluorophenyl)-1-[[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-10-[[(1-naphthalenylamino)-oxomethyl]amino]-6-oxo-3,4-dihydro-2H-1,5-benzoxazocin-2-yl]methyl]-1-methylurea
N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide
N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide
N-[(2S,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide
N-[(2S,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide
N-[(2R,3S)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide
N-[(2R,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
N-[(2S,3S)-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
N-[(2S,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-2-[[methyl-[(4-phenoxyphenyl)methyl]amino]methyl]-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-2-(1-tetrazolyl)acetamide
N-[(2R,3R)-2-[[1,3-benzodioxol-5-ylmethyl(methyl)amino]methyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-2,3,4,7-tetrahydro-1,5-benzoxazonin-9-yl]-4-fluorobenzenesulfonamide
O-[N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosaminyl]-L-threonine
A non-proteinogenic L-alpha-amino acid that is N-acetyl-alpha-neuraminyl-(2->6)-N-acetyl-alpha-D-galactosamine linked via an alpha glycosidic bond to the O at position 3 of L-threonine.
2-amino-3-[[3-butanoyloxy-2-[(5Z,8Z,11Z,14Z,17Z)-icosa-5,8,11,14,17-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C30H48NO10P (613.3015677999999)
2-amino-3-[[3-hexanoyloxy-2-[(3Z,6Z,9Z,12Z,15Z)-octadeca-3,6,9,12,15-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxypropanoic acid
C30H48NO10P (613.3015677999999)
3-[[3-acetyloxy-2-[(7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoyl]oxypropoxy]-hydroxyphosphoryl]oxy-2-aminopropanoic acid
C30H48NO10P (613.3015677999999)
Ferroxamine
A Fe(III)-complexed hydroxamate siderophore comprising equimolar amounts of iron(3+) and desferrioxamine B(3-)
methyl (4s)-4-(3-acetyl-2,6-dihydroxyphenyl)-4-(3-{[(2s,5r)-5-benzyl-3,6-dihydroxy-2,5-dihydropyrazin-2-yl]methyl}-1h-indol-2-yl)-2-methoxybutanoate
C34H35N3O8 (613.2424030000001)
{11-methoxy-9-[2-(3-methoxy-2-methylbut-1-en-1-yl)-1,3-oxazol-4-yl]-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl}oxyphosphonic acid
C30H48NO10P (613.3015677999999)
(3s,6s,7r)-6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
(1s,2r,3r,4r,5s,6s,8r,9r,10r,13s,16s,17r,18r)-8-(acetyloxy)-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-en-4-yl 4-methoxybenzoate
C33H43NO10 (613.2886818000001)
(2s,5s,8s,11s,14s,15r)-5-benzyl-15-ethyl-4,17-dihydroxy-8-isopropyl-2,6,9,11,14-pentamethyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione
C31H43N5O6S (613.2933898000001)
[(1e,7e,9e)-3-(2-aminoethyl)-1-(3-ethyl-6-oxo-2,3-dihydropyran-2-yl)-3,6-dihydroxy-10-{3-[(2-methylbutanoyl)oxy]cyclohexyl}deca-1,7,9-trien-4-yl]oxyphosphonic acid
C30H48NO10P (613.3015677999999)
5-benzyl-15-ethyl-4,17-dihydroxy-8-isopropyl-2,6,9,11,14-pentamethyl-12-oxa-20-thia-3,6,9,16,21-pentaazabicyclo[16.2.1]henicosa-1(21),3,16,18-tetraene-7,10,13-trione
C31H43N5O6S (613.2933898000001)
(1r,3s,5s,6r,7s)-6-hydroxy-8-methyl-7-{[(2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl (2e)-3-(3,4,5-trimethoxyphenyl)prop-2-enoate
1-hydroxy-4-[5-hydroxy-2,2-dimethyl-10-(2-methylbut-3-en-2-yl)-8-oxo-3h,4h-pyrano[3,2-g]chromen-4-yl]-3,5,6-trimethoxy-10h-acridin-9-one
(2r,3r,6s,8r,9r,10s,13s,17r)-8-(acetyloxy)-11-formyl-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadecan-4-yl benzoate
C33H43NO10 (613.2886818000001)
8-(acetyloxy)-5-hydroxy-6,16,18-trimethoxy-13-(methoxymethyl)-11-azahexacyclo[7.7.2.1²,⁵.0¹,¹⁰.0³,⁸.0¹³,¹⁷]nonadec-11-en-4-yl 4-methoxybenzoate
C33H43NO10 (613.2886818000001)
[(1r,3s,4s,6s,9s,11s,15r)-11-methoxy-9-{2-[(1e,3r)-3-methoxy-2-methylbut-1-en-1-yl]-1,3-oxazol-4-yl}-4,6-dimethyl-17-methylidene-7-oxo-8,19-dioxabicyclo[13.3.1]nonadecan-3-yl]oxyphosphonic acid
C30H48NO10P (613.3015677999999)
6-hydroxy-8-methyl-7-{[3-(3,4,5-trimethoxyphenyl)prop-2-enoyl]oxy}-8-azabicyclo[3.2.1]octan-3-yl 3-(3,4,5-trimethoxyphenyl)prop-2-enoate
[(1e,7e,9e)-3-(2-aminoethyl)-1-(3-ethyl-6-oxo-2,3-dihydropyran-2-yl)-3,6-dihydroxy-10-{3-[(3-methylbutanoyl)oxy]cyclohexyl}deca-1,7,9-trien-4-yl]oxyphosphonic acid
C30H48NO10P (613.3015677999999)